Immune Design (IMDZ) Names Sergey Yurasov SVP of Clinical Development and Chief Medical Officer
Go back to Immune Design (IMDZ) Names Sergey Yurasov SVP of Clinical Development and Chief Medical Officer(NASDAQ: IMDZ) | Delayed: 5.85 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.85 | 52 Week High | $23.55 | |||
Open | $17.64 | 52 Week Low | $4.50 | |||
Day High | $5.85 | P/E | N/A | |||
Day Low | $5.85 | EPS | $0.00 | |||
Volume | 192,912 |